Estrogen receptor-β modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells

Journal of Cellular Biochemistry

Volumn 89, Issue 1, 2003, Pages 152-164

  Cao, Lihuan ^a   Bu, Rongfa ^a   Oakley, Jennifer I ^a   Kalla, Sara E ^a   Blair, Harry C ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

BMP 2; CSF 1; Estrogen related receptor; Osteoclast; Osteoporosis; RANKL

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLONY STIMULATING FACTOR 1; ESTROGEN BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MATRIX PROTEIN; NOGGIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE MASS; BONE MATRIX; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN SYNTHESIS; GROWTH PLATE; HORMONAL REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETON; STEM CELL; WILD TYPE;

BASE SEQUENCE; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; DNA, ANTISENSE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

ERINACEIDAE;

EID: 0037405088     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10486     Document Type: Article

References (43)

1. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC. 2001. Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276:17808-17814.
2. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Lowik CW, Pols HA, van Leeuwen JP. 1997. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138:5067-5070.
3. Blair HC, Jordan SE, Peterson G, Barnes S. 1996. Variable effects of tyrosine kinase inhibitiors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 60:629-637.
4. Blair HC, Sidonio RF, Friedberg RC, Khan NN, Dong S-S. 2000. Proteinase expression during differentiation of human osteoclasts in vitro. J Cell Biochem 78:627-637.
5. Bonnelye E, Aubin JE. 2002. Differential expression of estrogen receptor-related receptor α and estrogen receptors α and β in osteoblasts in vivo and in vitro. J Bone Miner Res 17:1392-1400.
6. Bonnelye E, Vanacker JM, Dittmar T, Begue A, Desbiens X, Denhardt DT, Aubin JE, Laudet V, Fournier B. 1997. The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. Mol Endocrinology 11:905-916.
7. Bonnelye E, Merdad L, Kung V, Aubin JE. 2001. The orphan nuclear estrogen receptor-related receptor-α (ERRα) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 153:971-984.
8. Brubaker KD, Gay CV. 1999. Depolarization of osteoclast plasma membrane potential by 17β-estradiol. J Bone Miner Res 14:1861-1866.
9. Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL, Zheng MH, Nicholson GC. 1998. Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology 139:1258-1267.
10. Compston JE. 2001. Sex steroids and bone. Physiol Rev 81: 419-447.
11. Davis VL, Couse JF, Gray TK, Korach KS. 1994. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res 9:983-991.
12. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC. 2002. Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74-83.
13. Heino TJ, Hentunen TA, Vaananen HK. 2002. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: Enhancement by estrogen. J Cell Biochem 85:185-197.
14. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2:1132-1136.
15. Jen KY, Gewirtz AM. 2000. Suppression of gene expression by targeted disruption of messenger RNA: Available options and current strategies. Stem Cells 18:307-319.
16. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M. 1997. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489-495.
17. Kanatani M, Sugimoto T, Takahashi Y, Kaji H, Kitazawa R, Chihara K. 1998. Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation. J Bone Miner Res 13: 854-862.
18. Lambertini E, Penolazzi L, Aguiari G, del Senno L, Pezzetti F, Sollazzo V, Piva R. 2002. Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor α gene. Biochem Biophys Res Commun 292: 761-770.
19. Lindberg MK, Erlandsson M, Alatalo SL, Windahl S, Andersson G, Halleen JM, Carlsten H, Gustafsson JA, Ohlsson C. 2001. Estrogen receptor α, but not estrogen receptor β, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. J Endocrinology 171:425-433.
20. Lu D, Giguere V. 2001. Requirement of Ras-dependent pathways for activation of the transforming growth factor β promoter by estradiol. Endocrinology 142: 751-759.
21. McCauley LK. 2001. Transgenic mouse models of metabolic bone disease. Curr Opin Rheumatol 13:316-325.
22. Ogawa S, Fujita M, Ishii Y, Tsurukami H, Hirabayashi M, Ikeda K, Orimo A, Hosoi T, Ueda M, Nakamura T, Ouchi Y, Muramatsu M, Inoue S. 2000. Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor α and β pathways. J Biol Chem 275:21372-21379.
23. Onoe Y, Miyaura C, Ohta H, Nozawa S, Suda T. 1997. Expression of estrogen receptor β in rat bone. Endocrinology 138:4509-4512.
24. Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK. 2001. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 142:5371-5378.
25. Plant A, Tobias JH. 2001. Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice. J Cell Biochem 82: 683-691.
26. Qu Q, Harkonen PL, Vaananen HK. 1999. Comparative effects of estrogen and antiestrogens on differentiation of osteoblasts in mouse bone marrow culture. J Cell Biochem 73:500-507.
27. Rickard DJ, Waters KM, Ruesink TJ, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Riggs BL, Spelsberg TC. 2002. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts. J Bone Miner Res 17:580-592.
28. Rizzoli R, Bonjour JP, Ferrari S. 2001. Osteoporosis, genetics and hormones. J Mol Endocrinology 26:79-94.
29. Robinson JA, Harris SA, Riggs BL, Spelsberg TC. 1997. Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138:2919-2927.
30. Saika M, Inoue D, Kido S, Matsumoto T. 2001. 17β-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-α. Endocrinology 142:2205-2212.
31. Sapolsky RJ, Lipshutz RJ. 1996. Mapping genomic library clones using oligonucleotide arrays. Genomics 33:445-456.
32. Sarma U, Edwards M, Motoyoshi K, Flanagan AM. 1998. Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures. J Cell Physiol 175:99-108.
33. Schiller C, Gruber R, Redlich K, Ho GM, Katzgraber F, Willheim M, Pietschmann P, Peterlik M. 1997. 17β-estradiol antagonizes effects of 1α,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures. Endocrinology 138:4567-4571.
34. Shevde NK, Bendixen AC, Dienger KM, Pike JW. 2000. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97: 7829-7834.
35. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano M, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
36. Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP, Pacifici R. 1998. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest 102:1850-1859.
37. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. 2001. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation. J Biol Chem 276: 8836-8840.
38. Tomkinson A, Reeve J, Shaw RW, Noble BS. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinology Metab 82:3128-3135.
39. Tou L, Quibria N, Alexander JM. 2001. Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs). Mol Cell Endocrinology 183:71-79.
40. Waters KM, Rickard DJ, Riggs BL, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Moore J, Spelsberg TC. 2001. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem 83:448-462.
41. Watts CK, King RJ. 1994. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk. J Bone Miner Res 9:1251-1258.
42. Windahl SH, Hollberg K, Vidal O, Gustafsson JA, Ohlsson C, Andersson G. 2001. Female estrogen receptor β-/- mice are partially protected against age-related trabecular bone loss. J Bone Miner Res 16: 1388-1398.
43. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D. 2001. Estrogen modulates estrogen receptor α and β expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem 81(S36):144-155.